Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes.
OBJECTIVE
Dysfunction of the hypothalamus-pituitary-adrenal (HPA) axis has been implicated in type 2 diabetes (T2D). The aim of this study was to investigate the impact of T2D and gender on the HPA axis.


METHODS
Synthetic ACTH (1 μg) was administered to 21 subjects with T2D (age 62 (54-70) years, 11 men/ten women, HbA1c 49±2 mmol/mol, treated with diet or oral antidiabetic drugs) and 38 controls (age 58 (41-67) years, 20 men/18 women). Fasting basal B-glucose, serum cortisol, insulin, IGF1 and IGFBP1 concentrations were measured, and sampling for all but IGF1 was repeated 30, 60, and 90 min after ACTH injection. Patients took 0.25 mg dexamethasone at 2200-2300 h and returned the next morning for the measurement of serum cortisol concentration.


METHODS
Cross-sectional study.


RESULTS
Patients with T2D had similar fasting serum cortisol, IGF1 and IGFBP1 concentrations; however, serum cortisol concentration after administration of dexamethasone did not differ between the groups. Healthy women exhibited higher peak cortisol levels compared with healthy men (675±26 vs 582±21 nmol/l, P=0.014), while the peak levels were equally high in men and women with T2D, resulting in a higher peak level in men with T2D compared with healthy men (691±42 vs 582±21 nmol/l, P=0.024). Serum cortisol concentration after administration of dexamethasone did not differ between the groups, nor did IGF1 and IGFBP1.
Some studies have previously indicated disturbed regulation of the hypothalamus-pituitary-adrenal (HPA) axis in subjects with type 2 diabetes (T2D); however, much remains unknown in this area. To the best of our knowledge, this is the first study to show that the gender difference in the adrenal response to ACTH (with greater reactivity in women) is abolished in T2D. While the clinical implications cannot be determined by this paper, it is known that gender differences exist in the pathogenesis and complications of T2D. Thus, our findings suggest that further research into gender differences in the HPA axis is warranted.


CONCLUSIONS
Gender differences in adrenal response to ACTH were abolished in T2D. Men with T2D had a higher peak cortisol compared with controls. Further studies are needed to elucidate the clinical implications.
Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden.
Lisa
L
Arnetz
Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden.
Neda
N
Rajamand Ekberg
Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden.
Kerstin
K
Brismar
Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden Departments of EndocrinologyMetabolism and DiabetesMolecular Medicine and SurgeryKarolinska Institutet, Karolinska University Hospital Solna, D2:04, 17176 Stockholm, Sweden michael.alvarsson@karolinska.se.
Michael
M
Alvarsson
HPA axis; IGF1; IGFBP1; cortisol; diabetes; gender